Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11745768 | 0.98 | TSHR (0.46) | TSHRALDH1A1LMNAHRH4HRH3 | |
| SCHEMBL24672926 | 0.98 | TSHR (0.46) | TSHRALDH1A1LMNAHRH4HRH3 | |
| SCHEMBL31588184 | 0.98 | TSHR (0.46) | TSHRALDH1A1LMNAHRH4HRH3 | |
| SCHEMBL23696464 | 0.98 | TSHR (0.46) | TSHRALDH1A1LMNAHRH4HRH3 | |
| SCHEMBL4540412 | 0.93 | — | — | |
| SCHEMBL7565303 | 0.82 | — | — | |
| SCHEMBL2600364 | 0.79 | HRH4 (0.43) | ALDH1A1HRH4HRH3KDM4E | |
| SCHEMBL23959466 | 0.77 | TSHR (0.40) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL19233596 | 0.77 | TSHR (0.35) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL7672129 | 0.76 | TSHR (0.42) | TSHRALDH1A1HRH4HRH3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4437009-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2024-10-02 | — | — | EP | claimed |
| EP-4437016-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2024-10-02 | — | — | EP | claimed |
| EP-4247866-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2023-09-27 | — | — | EP | claimed |
| WO-2023088853-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-25 | — | — | WO | claimed |
| WO-2023088855-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-25 | — | — | WO | claimed |
| WO-2022106689-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-05-27 | — | — | WO | claimed |
| EP-4437016-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2024-10-02 | — | — | EP | disclosed |
| EP-4437009-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2024-10-02 | — | — | EP | disclosed |
| CN-118234765-A | Solution process for producing functionalized polyolefin | SABIC环球技术有限责任公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118215688-A | Solution process for producing functionalized polyolefin | SABIC环球技术有限责任公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-116368163-A | Solution process for producing functionalized polyolefin | SABIC环球技术有限责任公司 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023088853-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023088855-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-25 | — | — | WO | disclosed |
| WO-2022192162-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | FOX CHASE CHEMICAL DIVERSITY CENTER, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| US-9579400-B2 | Nanocarriers for drug delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-02-28 | — | — | US | disclosed |
| EP-2079479-B1 | HCV NS3 PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2014-11-26 | — | — | EP | disclosed |
| EP-1913016-B1 | MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2013-01-16 | — | — | EP | disclosed |
| US-8278322-B2 | HCV NS3 protease inhibitors | MERCK SHARP & DOHME CORP. (US) | 2012-10-02 | — | — | US | disclosed |
| US-20110028494-A1 | HCV NS3 Protease Inhibitors | MERCK SHARP & DOHME LLC | 2011-02-03 | — | — | US | disclosed |
| WO-2008051475-A2 | HCV NS3 PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028494-A1 | HCV NS3 Protease Inhibitors | HAVCR2, GTF3C3, CTSC | TSHR 4610/4885ALDH1A1 1199/4885LMNA 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.